Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Rhea-AI Summary

Quanterix (NASDAQ: QTRX) has scheduled its fourth quarter and full year 2024 financial results announcement for March 17, 2025. The company will release the results after market close, followed by a conference call at 4:30 p.m. E.T. on the same day.

Investors can participate in the live conference call by dialing 888-596-4144 or 646-968-2525 with Conference ID: 4306988. A live webcast will be available on the News & Events page in the Investors section of Quanterix's website, with the webcast replay remaining accessible for one year.

BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, March 17, 2025, at 4:30 p.m. E.T., to discuss its fourth quarter and full year 2024 financial results.

Quanterix will issue a press release regarding fourth quarter and full year 2024 financial results prior to the conference call on Monday, March 17, 2025, after the market closes. The press release will be posted on the Quanterix website at https://www.quanterix.com/.

To listen to the live conference call, investors can dial 888-596-4144 or 646-968-2525 and enter in Conference ID: 4306988. Interested investors can also access the live webcast from the News & Events page within the Investors section of the Quanterix website at http://www.quanterix.com. An archived webcast replay will be available on the Company’s website for one year.

About Quanterix

From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa^® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 3,200 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix’ filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250313126373/en/

Media Contact:

Marissa Klaassen

(978) 488-1854

media@quanterix.com

Investor Relations Contact:

Joshua Young

(508) 846-3327

ir@quanterix.com

Source: Quanterix Corporation

FAQ

When will Quanterix (QTRX) release its Q4 and full year 2024 earnings?

Quanterix will release its Q4 and full year 2024 earnings on March 17, 2025, after market close.

What time is Quanterix's (QTRX) Q4 2024 earnings call?

The earnings conference call is scheduled for 4:30 p.m. E.T. on March 17, 2025.

How can investors access Quanterix's (QTRX) Q4 2024 earnings call?

Investors can dial 888-596-4144 or 646-968-2525 (Conference ID: 4306988) or access the live webcast on Quanterix's website.

How long will Quanterix's (QTRX) Q4 2024 earnings webcast be available?

The webcast replay will be available on the company's website for one year.